Skip to content
The Nexus
DossierENTITY

geopolitical scrutiny

Coverage of geopolitical scrutiny in the Nexus archive.

Earliest in view: Jun 21 · 01:30 UTCMost recent: Jun 21 · 01:30 UTC
Co-mentioned in this coverage
Diederik Stadigperson1ING Researchorganization1United Statesplace1Chinaplace1biotech dealstopic1investment linkstopic1
Recent coverage
  • BUSINESSJun 21 · 01:30 UTCSCMP CHINA
    Cross-border biotech deals grow more complex as US targets China investment links

    Cross-border biotech deals between China and the United States are becoming more complex due to increased U.S. efforts to restrict investment and technology transfers, with analysts predicting a modest slowdown. Geopolitical scrutiny is expected to lead to fewer deals, according to ING Research's Diederik Stadig.